The potential use of stem cell‐based therapies for the repair and regeneration of various
tissues and organs offers a paradigm shift that may provide alternative therapeutic solutions …

Stem cell therapy holds the promise to treat degenerative diseases, cancer and repair of
damaged tissues for which there are currently no or limited therapeutic options. The …

Adipose tissue-derived mesenchymal stem cells (AdMSCs) represent an attractive and
ethical cell source for stem cell therapy. With the recent demonstration of MSC homing …

Objective External fistulas represent a disabling manifestation of Crohn's disease with a
difficult curability and a high relapse rate despite a large therapeutic armamentarium. Stem …

Mesenchymal stem cells (MSCs) derived from adipose tissue, bone marrow, cord blood, and
other tissues, have recently attracted much attention as potential therapeutic agents in …

In the past decade, the therapeutic value of mesenchymal stromal cells (MSCs) has been
studied in various indications, thereby taking advantage of their immunosuppressive …

Purpose The management of perianal fistula in patients with Crohn's disease is an
extremely challenging medical problem as many fistulas do not respond to available …

The discovery that mesenchymal stem cells (MSCs) are recruited into tumors has led to a
great deal of interest over the past decade in the function of MSCs in tumors. To address …

This review describes the historical emergence of the concept of bone marrow
mesenchymal stem cells (MSCs), summarizing data on Wolf and Trentin's hematopoietic …

Mesenchymal stem/stromal cells (MSC) show widespread application for a variety of clinical
conditions; therefore, their use necessitates continuous monitoring of their safety. The risk …